Martin Schalling

Martin Schalling is a Swedish psychiatrist and geneticist. Martin is currently the co-founder and senior advisor at Care to Translate, a company that provides communication services for mental health care providers. Martin has also served on the board of directors for Greenleaf Medical, a nutraceutical company focused on metabolic health.

Martin received their MD from the Karolinska Institutet in Stockholm, Sweden. Martin then did a postdoc at the Massachusetts Institute of Technology (MIT) in the US, where they researched genetics and neuroscience. Martin returned to Sweden to work at the University of California, San Diego on a sabbatical focused on psychiatric genetics.

In 2002, Martin founded Suicide Zero, a Swedish non-profit dedicated to suicide prevention. In 2013, they co-founded Care to Translate with the goal of making mental health care more accessible by providing communication services in multiple languages.

Martin Schalling studied medicine at the Karolinska Institutet and then attended the Nya Elementars gymnasium for a degree in natural sciences.